LPL Financial
XFOR icon

LPL Financial’s X4 Pharmaceuticals XFOR Stock Holding History

LPL Financial’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-383
Closed -$8.44K – 5536
2024
Q4 		$8.44K Hold
383
– – ﹤0.01% 5259
2024
Q3 		$7.7K Hold
383
– – ﹤0.01% 5142
2024
Q2 		$6.67K Hold
383
– – ﹤0.01% 4989
2024
Q1 		$16K Hold
383
– – ﹤0.01% 4861
2023
Q4 		$9.64K Buy
383
+33
+9% +$802 ﹤0.01% 4761
2023
Q3 		$11.4K Buy
+350
New +$15.3K ﹤0.01% 4640

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial's XFOR Position: Q1 2025 in Review

LPL Financial sold out of X4 Pharmaceuticals (XFOR) in Q1 2025, closing a stake of 383 shares — an estimated $8.44K sold.

LPL Financial first reported a position in XFOR in Q3 2023 and held it in 6 quarters. The position peaked at $16K in Q1 2024. 93 funds tracked by Wall St. Rank hold XFOR as of Q1 2025.

  • LPL Financial reported no remaining X4 Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • LPL Financial sold 383 X4 Pharmaceuticals shares in Q1 2025, an estimated $8.44K.
  • LPL Financial first reported a position in X4 Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • LPL Financial's X4 Pharmaceuticals position peaked at $16K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2025.

Based on LPL Financial's 13F filing for Q1 2025, filed 7 May 2025.